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Abstract
We propose a mathematical model for computing drug release from multi-layer cap-
sules. The diffusion problem in such heterogeneous layer-by-layer composite medium is
described by a system of coupled partial differential equations, which we solve analyti-
cally using separation of variables. In addition to the conventional interlayer continuous
mass transfer boundary conditions, we consider also the case of finite mass transfer re-
sistance, which corresponds to the case of a coated capsule. The drug concentration
in the core and through all layers, as well as in the external release medium, is then
given in terms of a Fourier series that we compute numerically to characterize the drug
release mechanism.
1 Introduction
Nowadays, there is a tremendous increasing interest in using capsules, beside other
sub-micrometer bodies such as nanoparticles, as targeted drug delivery systems [1].
They allow enhancing therapeutic efficacy and reduce side effects by controlling the
drug dose released in the human body. Capsules consist usually of a drug-loaded core
(fluid or solid) surrounded by more than one hydrogel layer. Such encapsulation with
multiple layers enhances the capsule mechanical stability, its biocompatibility, protects
the active ingredients from external chemical aggression and premature degradation,
and it allows extending the sustainability of the drug release [2, 3]. Different tech-
nologies have emerged in the last years to design and build layer-by-layer concentric
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spherical capsules [4, 5], even though the release of their encapsulated drug cannot
be fully predetermined. For some specific applications, a thin coating shell (or mem-
brane) is required to envelop the whole capsule structure in order to protect it from
external chemical aggressions and mechanical erosion. Depending on the nature of the
encapsulated formulations and according to the final aimed therapeutic requirements
the typical size of capsules can range from some nano-meters to milli-meters. For
biomedical applications, micro-capsules are largely used [6].
Drug release characterization consists in tracking the kinetics of the drug eluted
from the capsule into the external targeted medium, which is away from being an easy
task in both cases in situ and in vivo. However, effort and costs of developing and
designing new optimized delivery devices can be dramatically reduced if the release
mechanism is understood in advance using appropriate in silico models [7, 8, 9]. A
number of review papers have summarized previously proposed models for drug release
either from coated formulations [10, 11] or from polymeric matrices [8]. There are also
reviews on drug release from capsules [3, 12, 13, 14], most of them dealing with empirical
models. Here, we are rather interested in mechanistic models, because they allow a
better understanding of the underlying mechanism of the drug release by tracking the
influence of each physical input parameter, in contrast to the empirical models. We
upgrade existing mechanistic models by extending their applications to the multi-layer
uncoated and coated capsules. Thus, predictable simulations based on those models
can spot the significant physical parameters and allow extracting reliable assessment for
conducting in vitro, in situ and in vivo experiments. Diffusion is by far the dominant
mechanism in drug delivery beside other physico-chemical factors, such as osmosis, drug
dissolution, and polymer swelling [10]. Most of the previous suggested mathematical
models for release from spheres, as well as dissolved or dispersed drug systems, rely
on oversimplifying assumptions, such as considering a constant diffusion rate and a
well stirred (or at constant concentration) release medium [15], as summarized in the
review by Arifin et al [16]. Mass flux resistance at the coating shell for the coated
capsules is not properly addressed in literature.
In this article, we will make a step forward by studying theoretically for the first
time the drug release from a multi-layer capsule, via a semi-analytic procedure, and
moreover by avoiding considering simplistic hypothesis made elsewhere previously, such
constant and continuous concentration at the capsule surface. A general presentation
of a pure diffusive model through a composed layer-by-layer medium is given in Sect.
2. The specific case of a spherical core-layer capsule coated with a protective thin shell
is addressed in Sect. 3, with a mathematical treatment somehow similar to the one we
previously used for other drug-eluting systems [17, 18]. Here we describe in detail this
method and how to use it for the problem at hand. Special care is taken when setting
the interlayer conditions, including the finite resistance (jump in the concentration
value) at the external coated shell. An analytic expression for the concentration and
the cumulative mass in all layers are given in Sect. 4. Finally numerical simulations are
used to study the sensitivity of the system to various parameters and configurations.
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2 A general model for drug release from a multi-
layer capsule
Let us consider a multi-layer capsule made of a drug-filled core (the depot, Ω0)
surrounded by a successive number of layers (Ωi, with i = 1, 2, ..., n) as illustrated
in Fig. 1. These enveloping layers are constituted of different, but homogeneous and
isotropic materials, which are customized to allow selective diffusion, to better control
the release rate and sometimes to host more than one drug [6]. The last protective
outer shell is in contact with the targeted release medium Ωs (either a bulk fluid or
tissue), here of finite extent, with boundaries "far enough" from the capsule surface.
Even in such a simple configuration where the transport is driven by pure diffusion,
predicting drug kinetics is not an easy task.
In the core Ω0, we assume that the drug dissolution occurs in a short time compared
to that of diffusion and thus, can be considered as instantaneous [19]. Therefore, the
drug diffusion in Ω0 can be described by the second Fick’s law:
∂c0
∂t
= D0∇2c0 in Ω0, (2.1)
where c0 is the concentration field and D0 is the diffusion coefficient of the drug in the
core. Analogously, in the surrounding layers and in the release medium Ωs, we have
similar diffusion equations
∂ci
∂t
= Di∇2ci inΩi i = 1, 2, ..., n, s (2.2)
with Di is the diffusion coefficient in the i-th layer Ωi (any possible convection, as in
Ref. [20] or reaction terms in Ωs are excluded). We set a perfect sink condition far
away (see Sect. 3):
cs = 0 at ∂Ωs, t > 0 (2.3)
The initial condition for concentrations:
ci(·, 0) = fi(·) in Ωi i = 0, 1, ..., n, s (2.4)
are given in all layers.
Here, we refrain from using two widely exploited over-simplistic assumptions [15,
16], i.e.:
i) c0 is constant at core surface ∂Ω0, as if there is a sustained source of drug;
ii) cs is uniform in the release medium Ωs, as in well-stirred medium.
Modelling interlayer boundary conditions
At each interface between two adjacent layers, flux continuity holds:
−Di∇ci · n = −Di+1∇ci+1 · n at ∂Ωi ∩ ∂Ωi+1 (2.5)
with n the surface external normal vector. Moreover, a non-perfect contact is present
at the interlayers [21]:
ci = σici+1, at ∂Ωi ∩ ∂Ωi+1 (2.6)
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where σi is the drug partition coefficient between layers i and i+ 1.
Modelling the external coating shell
To prevent fast delivery, the capsule’s outmost layer Ωn is protected with a thin semi-
permeable shell (coating) Ωm having a small, yet finite thickness (h), see Fig. 2. This
coating shields and preserves the encapsulated drug from degradation and fluid convec-
tion, protects the capsule structure, and guarantees a more controlled and sustained
release [12]. Instead of using a distributed model as above, we model the drug diffu-
sion across Ωm by setting a simple interface boundary condition between Ωn and Ωs
that incorporates the physical properties of the coating shell as follows. The mass flux
across Ωm is proportional to the concentration gradient:
Jm = −Dm∇cm (2.7)
whereDm is the diffusion coefficient in the coating shell. Let σn and σm be the partition
coefficients (i.e. the ratio of the left/right concentrations at the equilibrium, see Fig.
2) of drug on both interfacial sides of the coating shell :
σn =
cn
c−m
, σm =
c+m
cs
(2.8)
By applying Eq. (2.7) across the coating shell thickness h (fig 2, right zoom), we get:
Jm · n = −Dm c
+
m − c−m
h
= Dm
h
(
cn
σn
− σmcs
)
= Dm
hσn
(cn − σnσmcs) (2.9)
This can be viewed as an additional boundary condition, of different nature, imposed
at the interface separating Ωn and Ωs. Thus, in case of having coating shell, Eqns
(2.5)–(2.6) are then replaced with:
−Dn∇cn · n = −Ds∇cs · n = P (cn − Σcs) at ∂Ωn ∩ ∂Ωs (2.10)
where P = Dm
hσn
is mass transfer coefficient (ms−1) and Σ = σnσm.
Equation (2.10) lumps the distributed model in Ωm into a simpler interlayer bound-
ary condition, where P reflects the shell mass transfer properties into one single easily
measurable coefficient that is related to the permeability [21]. At the coating shell
surface, we use the interlayer finite resistance Eq. (2.10) rather than Eq. (2.6).
3 A case study: a spherical core-shell capsule
The two-layer capsule is currently the most used and in this section we consider
this special case: a drug-filled core Ω0 encapsulated by a single polymeric shell Ω1 and
surrounded by the release medium Ω2: each medium has the shape of concentric sphere
of increasing radius, R0, R1, R∞ respectively (with R0 < R1  R∞). This method can
be easily extended, with a more complicated algebra, to any number of layers. Due to
the homogeneity and isotropy, we can assume that net drug diffusion occurs along the
radial direction only, and thus we restrict our study to a one-dimensional model (Fig.
4
2) that reflects a perfectly radially symmetric system. Thus, the general formulation
given in Section 2 reduces to a three coupled equations problem, that in 1D radial
symmetry reads:
∂c0
∂t
= D0
(
∂2c0
∂r2
+ 2
r
∂c0
∂r
)
= D0
r2
∂
∂r
(
r2
∂c0
∂r
)
in (0, R0) (3.1)
∂c1
∂t
= D1
(
∂2c1
∂r2
+ 2
r
∂c1
∂r
)
= D1
r2
∂
∂r
(
r2
∂c1
∂r
)
in (R0, R1) (3.2)
∂c2
∂t
= D2
(
∂2c2
∂r2
+ 2
r
∂c2
∂r
)
= D2
r2
∂
∂r
(
r2
∂c2
∂r
)
in (R1, R∞) (3.3)
∂c0
∂r
= 0 at r = 0 (3.4)
−D0∂c0
∂r
= −D1∂c1
∂r
, c0 = σ0c1 at r = R0 (3.5)
−D1∂c1
∂r
= −D2∂c2
∂r
, c1 = σ1c2 at r = R1 (3.6)
c2 = 0 at r = R∞ (3.7)
where r is the radial coordinate position. In case of having a coating shell Ωm Eq.
(3.6) is replaced with (see Eq. (2.10)):
−D1∂c1
∂r
= −D2∂c2
∂r
= P (c1 − Σc2) at r = R1
The initial condition for a releasing capsule is:
c0(r, 0) = C0 for 0 < r ≤ R0
c1(r, 0) = 0 for R0 < r ≤ R1
c2(r, 0) = 0 for R1 < r ≤ R∞ (3.8)
with C0 is the initial concentration of the loaded drug in the core.
The release distance
The release medium is here delimited by a cut-off finite distance R∞, whose range
is determined by the following considerations. Strictly speaking, for a pure diffusion
problem from a spherical source into a homogeneous medium having the diffusivity D,
the concentration field c(·, t) undergoes a exponential decay ∝ exp(−Dt). On the other
hand, at a given time, the concentration is gradually damped, going down to zero at
infinite distance.
For computational practical purposes, we set a cut-off length R∞, that we call
release distance or penetration depth, beyond which the concentration and as well as
the mass flux reduce to a given percentage of their initial values at a given time. More
precisely, the release distance is the minimum finite length such that: c(R∞, t) =
c0 ' 0 at time t, with  a tolerance. For 0 ≤ r ≤ R∞ the concentration decays
with time at exponential rate and the sink condition (3.7) holds at R∞ within a given
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tolerance, being c(r, t) ≈ 0 for r ≥ R∞. Analogously to the heat transfer problem,
R∞ is proportional to
√
Dt [22]. The precise estimation of the release distance in a
multi-layer medium is beyond the scope of this work, even though there are attempts to
compute it within a certain degree of accuracy. However, by considering a homogeneous
medium at constant concentration faced with the release medium, we get a conservative
overestimation of the release distance by R∞ =
√
10mDt, with  = 10−m [17].
3.1 Solving procedure
We use the separation of variables method to solve the three-layer equation model,
as done in other composite release systems [17, 18]. To this purpose, it would be
convenient to recast the above equations in a dimensionless form.
Scaling
All the variables, the parameters and the equations are normalized by means of the
change of variables:
r → r
R∞
t→ Dmax
R2∞
t ci → ci
C0
(3.9)
and by introducing the nondimensional constants:
R0/1/∞ =
R0/1/∞
R∞
γi =
Di
Dmax
φ = PR∞
Dmax
(3.10)
where subscript max denotes the maximum value across the 3 layers. By separating
ci(r, t) = Fi(r)Gi(t), Eqs. (3.1)–(3.3) become:
1
γi
G′i
Gi
= (r
2F ′i )′
r2Fi
= −λ2i i = 0, 1, 2 (3.11)
that admits the solutions:
Fi(r) = ai
cos(λir)
r
+ bi
sin(λir)
r
, Gi(t) = exp(−γiλ2i t) i = 0, 1, 2 (3.12)
In order to retain a finite solution in r = 0, we set a0 = 0. By imposing G0 = G1 = G2,
we obtain
λi =
√
γ0
γi
λ0 i = 1, 2 (3.13)
The boundary condition (3.4) is automatically satisfied, whereas (3.5)–(3.7) read re-
spectively:
γ0F
′
0(R0) = γ1F ′1(R0) (3.14)
F0(R0) = σ0F1(R0) (3.15)
γ1F
′
1(R1) = γ2F ′2(R1) (3.16)
F1(R1) = σ1F2(R1) (3.17)
F2(1) = 0 (3.18)
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In case of having a coating shell Ωm, Eq. (3.17) has to be substituted in
γ1F
′
1(R1) + φ(F1(R1)− ΣF2(R1)) = 0 (3.19)
This set of 5 algebraic equations (3.14)-(3.18) form a homogeneous system with the
unknowns b0, a1, b1, a2, b2. By imposing the coefficient matrix to be singular and by
using Eq. (3.13), we get a relationship in λ0 (eigencondition). This problem is solved
numerically with MATLAB by a successive bisection method [23]. It admits an infinite
number of roots (λk0) with k = 1, 2, ..., and from them, the whole set of eigenvalues
(λki ) with i = 1, 2 and k = 1, 2, ... are determined. From each eigenvalue, the constants
aki , b
k
i are obtained subsequently from Eqs. (3.14) to (3.18), and the eigenfunctions
defined in Eq. (3.12) have the form:
F ki (r) = aki
cos(λki r)
r
+ bki
sin(λki r)
r
(3.20)
4 Computing drug concentration and mass
Once the eigenvalues λk0 are computed, the corresponding time-variable functions
Gki defined by Eqs. (3.12) are obtained as:
Gk0(t) = Gk1(t) = Gk2(t) = exp(−γ0(λk0)2t) (4.1)
Thus, the general solution of the problem (3.1) - (3.8) is given by a linear superposition
of the fundamental solutions (3.20) - (4.1) in the form:
ci(r, t) =
∞∑
k=1
AkFik(r) exp(−γi(λki )2t) i = 0, 1, 2 (4.2)
where the Fourier coefficients Ak are computed in accordance with the initial condi-
tions:
c0(r, 0) = 1 for 0 < r ≤ R0
c1(r, 0) = 0 for R0 < r ≤ R1
c2(r, 0) = 0 for R1 < r ≤ 1 (4.3)
By evaluating Eq. (4.2) at t = 0 and multiplying it by r2Fim we get after integration:
R0∫
0
∑
k
Akr
2F0kF0m dr =
R0∫
0
r2F0m dr m = 1, 2, .... (4.4)
R1∫
R0
∑
k
Akr
2F1kF1m dr = 0 m = 1, 2, .... (4.5)
1∫
R1
∑
k
Akr
2F2kF2m dr = 0 m = 1, 2, .... (4.6)
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By summing (4.4) with (4.5) multiplied by σ0 and with (4.6) multiplied by σ0σ1, and
by the orthogonality of F0k, F1k, F2k (see appendix) we have:
Ak
 R0∫
0
r2F 20kdr + σ0
R1∫
R0
r2F 21kdr + σ0σ1
1∫
R1
r2F 22kdr
 = R0∫
0
r2F0kdr (4.7)
By setting:
Ik =
R0∫
0
sin(λk0r)rdr =
[
sin(λk0r)
(λk0)2
− r cos(λ
k
0r)
λk0
]R0
0
= sin(λ
k
0R0)
(λk0)2
−R0 cos(λ
k
0R0)
λk0
(4.8)
we have:
Ak =
bk0Ik
Nk
(4.9)
with Nk is the norm (see appendix). The analytic form of the solution allows an easy
computation of the dimensionless drug mass (per unit of volume) in each domain as a
function of time as in Ref. [18]:
M0(t) =
R0∫
0
c0(r, t)dr M1(t) =
R1∫
R0
c1(r, t)dr M2(t) =
1∫
R1
c2(r, t)dr
By (4.2) we have:
M0(t) =
∑
k
Ak exp(−γ0(λk0)2t)
R0∫
0
Fk0(r)dr (4.10)
Similarly:
M1(t) =
∑
k
Ak exp(−γ1(λk1)2t)
R1∫
R0
Fk1(r)dr (4.11)
M2(t) =
∑
k
Ak exp(−γ2(λk2)2t)
1∫
R1
Fk2(r)dr (4.12)
In particular, we have:
M0(0) = R0 M1(0) = M2(0) = 0 (4.13)
Moreover, Eqs. (4.10), (4.11) and (4.12) show that lim
t→∞M0(t) = M1(t) = M2(t) = 0 .
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5 Results and discussion
The physical problem of drug release from a multi-layer capsule depends on a large
number of parameters. In this article, for simplicity, the following physical parameters
are chosen to simulate the release of substance from an uncoated and a coated core-
shell capsule. These typical values of geometrical and diffusion parameters are taken
from the work of Henning et al. [12]:
R0 = 1.5 · 10−3m R1 = 1.7 · 10−3m σ0 = σ1 = 1
D0 = 30 · 10−11m2s−1 D1 = 5 · 10−11m2s−1 D2 = 30 · 10−11m2s−1
and (5.1)
P = 5 · 10−8m/s Σ = 1 (for the coated capsule case)
For these input numerical values, the estimated release distance R∞ = 40 · 10−3m ≈
24R1 is sufficient to have the complete drug depletion from the core and a negligible
concentration by about 10 days. All the series appearing in the solution (see Eq. (4.2)
and what follow) have been truncated at a finite number of terms N = 100 for all times
reported in the simulation. A number of grid nodes proportional to the thickness of
the layer to guarantee a convenient resolution has been considered. For example, for
the layer’s sizes corresponding to the above parameters, a number of equidistributed
100, 14 and 2550 points has been selected, respectively.
Drug is transported differently in each layer, that receives mass from the previous
underneath layer and transmits it to the next above, in a cascade sequence until being
completely damped out at finite distance r ≤ 1. Fig. 3 shows the concentration
profiles in the case of uncoated and coated capsules, and reports lower values and a
more uniform distribution in all layers in the first case. Concentration is dropping
down inside each layer, being possibly discontinuous at the interlayer interfaces, with
the mass flux continuity preserved (Fig. 3). We also compute the fraction of drug mass
retained in each layer, defined as:
θi(t) =
Mi(t)
M0(0)
i = 0, 1, 2 (5.2)
Table 1 gives different distribution of θi(t) in each layer, both in the case without and
with the coating shell. Because we set the sink boundary condition (3.7), a mass loss
occurs out of the bound r = 1 and it is transferred to the surrounding bulk medium
(Me)1. In other words, due to the absorbing condition (3.7), all drug mass is transferred
at the external medium (e) at a sufficiently large time and the total mass is preserved
and equals its initial value (say the drug mass in the coating M0(0)), such that:
M0(0)−
2∑
i=0
Mi(t)−Me(t)
M0(0)
= 1−
2∑
i=0
θi(t)− θe = 0 (5.3)
1 The remaining infinite release medium is denoted by the subscript e.
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Table 1: Percentage of the drug mass θ retained in each layer (including the external semi-
infinite medium e) at different times. Left values are in the case without membrane, right
values with membrane, red values indicate the peak mass. The reported differences concern
mostly intermediate times, with the depletion time unaltered.
time ( s(' d : h : m)) θ0(%) θ1(%) θ2(%) θe(%)
100 (' 2m) 96− 96 3.4− 3.5 0.07− 0.006 0.8− 0.6
500 (' 8m) 85− 85 4.6− 6.6 2.0− 0.3 8.8− 7.8
1000 (' 17m) 72− 76 4.4− 7.5 3.9− 0.7 20− 16
2000 (' 33m) 52− 66 3.6− 7.5 5.9− 1.6 38− 25
5 · 103 (' 1h : 23m) 25− 53 2.0− 6.2 7.2− 3.0 66− 37
104 (' 2h : 47m) 9.7− 39 0.9− 4.5 6.1− 4.0 83− 53
5 · 104 (' 13h : 53m) 0.6− 3.8 0.07− 0.4 1.9− 2.4 97− 93
105 (' 1d : 4h) 0.2− 0.5 0.03− 0.06 1.0− 1.2 98− 98
5 · 105 (' 5d : 19h) 0.02− 0.02 0.002− 0.002 0.2− 0.2 99− 99
106 (' 11d : 14h) < 10−2− < 10−2 < 10−3− < 10−3 < 10−1− < 10−1 > 99− > 99
5 · 106 (' 57d : 21h) < 10−6− < 10−6 < 10−6− < 10−6 < 10−3− < 10−6 ≈ 100− ≈ 100
Due to the diffusive coefficient, the mass is exponentially decreasing in the core
(layer 0), but is first increasing up to some upper bound and then decaying asymptot-
ically in the layer 1 and 2 (Fig. 4). In the outmost layer (e) the mass accumulates
over an extended distance as the time proceeds. The simulation points out the time
of peak mass in the observable release medium (layer 2) is 4700s (≈ 1h:18min) for the
case without the coating shell, and 14800s (≈ 4h:7min) for the case with membrane,
demonstrating a prolonged release in the latter case. The thin layer 1 retains a negligi-
ble mass due to its thickness, and the core is completely emptied (θ(%) < 10−2) after
a period of about 11 days (Table 1). At that time, all the mass is transferred to the
external layer. However, a much sustained release occurs in the case with membrane
(Table 1 and Fig. 4) at intermediate times, with the final delivery time unchanged.
It appears that the relative size of the layers and their respective diffusivity affect
the whole drug release processes. Thus, it is worth identifying which set of parameters
guarantees a more prolonged and uniform release and what other values are responsible
for a localized peaked distribution followed by a faster decay. One of them is the per-
meability of the coating shell that offers a significant resistance to the mass flux. Thus,
the membrane properties have to be properly tuned in order to allow drug molecules
to be released, while maintained in the efficient therapeutic range with exceeding the
toxic dose and without dropping drown below an insufficient dose. These results can be
used to assess whether drug targets tissues at the desired rate and to optimize the dose
capacity given by thin surface coating shells for an extended period of time. Differently
than in other single layer models, the current formulation constitutes a simple tool to
predict the accurate drug release from a multi-layer capsule (uncoated and coated ones)
that can help in designing and in manufacturing new drug delivery platforms.
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6 Conclusions
Despite notable recent progress in designing and manufacturing drug release sys-
tems, the precise delivery characteristics and the development of multifunctional deliv-
ery carriers remains a challenge. Mathematical modeling has emerged in recent years
as an additional powerful alternative tool to simulate drug delivery processes and much
effort is currently addressed for a deeper understanding of the elution mechanism. The
release process from a capsule is not completely understood and can be influenced by
different concurrent physical and chemical factors. In this work we propose and use
a mechanistic model for studying the drug release from a multi-layer capsule under a
limited number of physical assumptions. The analytic form of the solution provides in-
sights into the drug mass transfer as well as the effect of design parameters, such as the
device geometry and drug loading, on the release mechanism. By showing the relation-
ship among the several variables and material diffusive properties, the present model
can be used to identify simple indexes or clinical indicators of biomedical significance
and to optimize drug elution towards a desired targeted organ or tissue. Thus, the
capsule design for a therapeutically optimal rate can be predicted using a systematic
approach with a minimum number of experimental studies.
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Appendix
Let us prove the orthogonality of the system Fi(r), i = 0, 1, 2 – see Eq. (3.12) – in
the interval [0, 1]. The Sturm-Liouville eigenvalue problems Eq. (3.11) can be written:
(r2F ′0)′ = −λ20r2F0 in [0, R0] (A.1)
F ′0(0) = 0 (A.2)
γ0F
′
0(R0) = γ1F ′1(R0) (A.3)
(r2F ′1)′ = −λ21r2F1 in [R0, R1] (A.4)
F0(R0) = σ0F1(R0) (A.5)
γ1F
′
1(R1) = γ2F ′2(R1) (A.6)
(r2F ′2)′ = −λ22r2F2 in [R1, 1] (A.7)
F1(R1) = σ1F2(R1) (A.8)
F2(1) = 0 (A.9)
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Let us consider two different eigenvalues λ0m and λ0n and the corresponding eigen-
functions F0m, F0n. Multiplying Eq. (A.1) by F0n and integrating:
λ20m
R0∫
0
r2F0mF0ndr = −
R0∫
0
(r2F ′0m)′F0ndr = −
[
r2F ′0mF0n
]R0
0 +
R0∫
0
r2F ′0mF
′
0ndr (A.10)
Similarly, for the eigenvalue λ0n
λ20n
R0∫
0
r2F0nF0mdr = −
R0∫
0
(r2F ′0n)′F0mdr = −
[
r2F ′0nF0m
]R0
0 +
R0∫
0
r2F ′0nF
′
0mdr (A.11)
Subtracting Eq. (A.11) from Eq. (A.10) we have:
(λ20m − λ20n)
R0∫
0
r2F0nF0mdr = −
[
r2F ′0mF0n
]R0
0 +
[
r2F ′0nF0m
]R0
0 (A.12)
Repeating a similar procedure for the Eq. (A.4) (resp. Eq. (A.7)), for the eigenvalues
λ1m, λ1n (resp. λ2m, λ2n ) and for the eigenfunctions F1m, F1n (resp. F2m, F2n), we get:
(λ21m − λ21n)
R1∫
R0
r2F1nF1mdr = −
[
r2F ′1mF1n
]R1
R0
+
[
r2F ′1nF1m
]R1
R0
(A.13)
(λ22m − λ22n)
1∫
R1
r2F2nF2mdr = −
[
r2F ′2mF2n
]1
R1
+
[
r2F ′2nF2m
]1
R1
(A.14)
Eq. (A.12) multiplied by γ0 and by use of (A.2) reads:
γ0(λ20m−λ20n)
R0∫
0
r2F0nF0mdr = −γ0R20F ′0m(R0)F0n(R0)+γ0R20F ′0n(R0)F0m(R0) (A.15)
Eq. (A.13) multiplied by γ1σ0 gives:
γ1(λ21m − λ21n)σ0
R1∫
R0
r2F1nF1mdr = −γ1R21σ0F ′1m(R1)F1n(R1) + γ1R20σ0F ′1m(R0)F1n(R0)+
γ1R
2
1σ0F
′
1n(R1)F1m(R1)− γ1R20σ0F ′1n(R0)F1m(R0) (A.16)
Finally Eq. (A.14) multiplied by γ2σ0σ1 and by use of (A.9) becomes:
γ2(λ22m−λ22n)σ0σ1
1∫
R1
r2F2nF2mdr = γ2R21σ0σ1F ′2m(R1)F2n(R1)−γ2R21σ0σ1F ′2n(R1)F2m(R1)
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(A.17)
By summing Eqs.(A.15), (A.16), (A.17) and by use of Eqs. (3.13), (A.3) and (A.6)
we get:
γ0(λ20m − λ20n)
 R0∫
0
r2F0nF0mdr + σ0
R1∫
R0
r2F1nF1mdr + σ0σ1
1∫
R1
r2F2nF2mdr
 =
γ0R
2
0F
′
0n(R0)[F0m(R0)− σ0F1m(R0)]− γ0R20F ′0m(R0)[F0n(R0)− σ0F1n(R0)]
+ γ1R21σ0F ′1n(R1)[F1m(R1)− σ1F2m(R1)]− γ1R21σ0F ′1m(R1)[F1n(R1)− σ1F2n(R1)]
(A.18)
Finally, by the use of (A.5) and (A.8), all terms at r.h.s. are zero and
R0∫
0
r2F0nF0mdr + σ0
R1∫
R0
r2F1nF1mdr + σ0σ1
1∫
R1
r2F2nF2mdr =
{
0 for m 6= n
Nm for m = n
(A.19)
with
Nm =
R0∫
0
(bm0 sin(λm0 r))2dr + σ0
R1∫
R0
(am1 cos(λm1 r) + bm1 sin(λm1 r))2dr
+σ0σ1
1∫
R1
(am2 cos(λm2 r) + bm2 sin(λm2 r))2dr > 0 (A.20)
the norm.
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Figure 1: Drug releasing from a multi-layer microcapsule. Drug is initially loaded in the core
Ω0 and diffuses, through all the intermediate layers Ωi, into the release medium Ωs confined
by the dashed line. Suitable conditions are set at internal interlayer interfaces and at the
external coating shell (figure not to scale).
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Figure 2: Schematic representation of the cross-section of the radially symmetric multi-layer
capsule, made of a central core Ω0, the concentric layer Ω1 and the possible thin coating shell
Ωm (in red). Together with the external release medium Ω2 - limited by the dashed line -
it constitutes a three concentric layers system. On the right side, a zoom of the distributed
coating layer shell (figure not to scale).
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Figure 3: Normalized concentration profiles in the three layers at three instants, in case
without (top) and with coating shell (bottom). At all observable times, all concentrations
are damped out at nondimensional distance r = 0.2. Note the slower release for the case
with the coating shell.
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Figure 4: Drug mass in the internal core (layer 0), in the layer (layer 1) and in the targeted
release medium (layer 2) in both cases without the coating shell (top), and with (bottom).
In the internal layer mass is monotonically decreasing, while in the others two there is a
characteristic time at which the drug reaches a peak. Note a more uniform and sustained
release in the second case.
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